Fig 1.
Overview of approach to developing the CAD algorithm in the RA cohort.
Fig 2.
Validation of the CAD algorithm in the IBD cohort.
Table 1.
Clinical characteristics of subjects in the RA, IBD and DM cohorts.
Table 2.
Variables in the final CAD algorithm.
Table 3.
Validation of accuracy of the two step classification of CAD (screening + algorithm) using structured data only, compared with the structured data + NLP.
Natural language processing = NLP; negative predictive value = NPV; positive predictive value = PPV.
Table 4.
Clinical characteristics of subjects classified with CAD in the RA, IBD and DM cohorts (PPV of CAD classification > = 90% PPV*).
Table 5.
Unadjusted and adjusted odds ratios comparing risk of CAD in IBD and RA to DM.